AdminJul 18, 20211 minAbSci sets IPO terms, valuing company at up to $1.5 billionAbSci Corp. ABSI, has set terms of its initial public offering, which could value the Washington-based provider of an artificial...
AdminJul 14, 20211 minProtein discovery and development platform AbSci sets terms for $200 million IPOAbSci, which provides a platform for the discovery and development of proteins and biologics, announced terms for its IPO on Thursday....
AdminJul 12, 20212 minHelicase Venture portfolio company Absci files for IPOhttps://seekingalpha.com/news/3711566-biotech-discovery-company-absci-files-for-ipo Absci Corp., a synthetic biology company whose...